Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1.

Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1.
复制标题

DOI:
10.1038/nm.2827
复制
发表时间:
2012-08
期刊:
影响因子:
82.9
通讯作者:
Glass, Rainer
Glass, Rainer
中科院分区:
医学1区
文献类型:
--
作者:
Stock, Kristin;Kumar, Jitender;Synowitz, Michael;Petrosino, Stefania;Imperatore, Roberta;Smith, Ewan St J.;Wend, Peter;Purfuerst, Bettina;Nuber, Ulrike A.;Gurok, Ulf;Matyash, Vitali;Waelzlein, Joo-Hee;Chirasani, Sridhar R.;Dittmar, Gunnar;Cravatt, Benjamin F.;Momma, Stefan;Lewin, Gary R.;Ligresti, Alessia;De Petrocellis, Luciano;Cristino, Luigia;Di Marzo, Vincenzo;Kettenmann, Helmut;Glass, Rainer

文献摘要

参考文献

被引文献

相似文献

世界卫生组织3级和4级原发性星形细胞瘤(hg -星形细胞瘤)在成人中占多数,尽管采用多种治疗方法,但几乎总是致命的。在这里,我们发现青少年大脑具有内源性防御hg星形细胞瘤的机制。神经前体细胞(Neural precursor cells, npc)通过释放一组对香草样蛋白受体(瞬时受体潜在香草样蛋白亚家族成员-1;TRPV1)具有激动作用的脂肪酸乙醇酰胺,向pg -星形细胞瘤迁移,减少胶质瘤的扩张,延长生存期。TRPV1在g -星形细胞瘤中的表达高于无瘤脑,TRPV1刺激通过内质网应激途径的激活转录因子-3 (ATF3)控制分支触发肿瘤细胞死亡。npc的抗肿瘤反应随着年龄的增长而消失。npc介导的肿瘤抑制可以通过全身给药合成香草素Arvanil在成人大脑中模拟,这表明TRPV1激动剂具有作为新的hg星形细胞瘤治疗药物的潜力。
Primary astrocytomas of World Health Organization grade 3 and grade 4 (HG-astrocytomas) are preponderant among adults and are almost invariably fatal despite multimodal therapy. Here, we show that the juvenile brain has an endogenous defense mechanism against HG-astrocytomas. Neural precursor cells (NPCs) migrate to HG-astrocytomas, reduce glioma expansion and prolong survival by releasing a group of fatty acid ethanolamides that have agonistic activity on the vanilloid receptor (transient receptor potential vanilloid subfamily member-1; TRPV1). TRPV1 expression is higher in HG-astrocytomas than in tumor-free brain and TRPV1 stimulation triggers tumor cell death via the activating transcription factor-3 (ATF3) controlled branch of the ER stress pathway. The anti-tumorigenic response of NPCs is lost with aging. NPC-mediated tumor suppression can be mimicked in the adult brain by systemic administration of the synthetic vanilloid Arvanil, suggesting that TRPV1 agonists hold potential as new HG-astrocytoma therapeutics.
DOI: 10.1093/brain/awq128
发表时间: 2010-07-01
期刊: BRAIN
影响因子: 14.5
作者:
Chirasani, Sridhar Reddy;Sternjak, Alexander;Glass, Rainer
通讯作者: Glass, Rainer
DOI: 10.1093/nar/gkg409
发表时间: 2003-06-15
影响因子: 14.9
作者:
Grünweller, A;Wyszko, E;Kurreck, J
通讯作者: Kurreck, J
DOI: 10.1073/pnas.0708228104
发表时间: 2007-10-23
影响因子: 11.1
作者:
Leuner, Benedetta;Kozorovitskiy, Yevgenia;Gould, Elizabeth
通讯作者: Gould, Elizabeth
DOI: 10.1523/jneurosci.0514-06.2006
发表时间: 2006-06-21
影响因子: 5.3
作者:
Assanah, Marcela;Lochhead, Richard;Canoll, Peter
通讯作者: Canoll, Peter
DOI: 10.1074/jbc.272.6.3315
发表时间: 1997-02-07
影响因子: 4.8
作者:
Bisogno, T;Maurelli, S;DiMarzo, V
通讯作者: DiMarzo, V